Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-07-10
2010-06-08
Royds, Leslie A (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07732439
ABSTRACT:
The present invention relates to a pharmaceutical composition which contains a compound of formulain which R1, R2, R3and R4are each n-butyl, where XP−is a counteranion and P is 1, 2 or 3, together with a pharmaceutically acceptable carrier, excipient or adjuvant.
REFERENCES:
patent: 3579339 (1971-05-01), Chang et al.
patent: 4622395 (1986-11-01), Bellus et al.
patent: 4880769 (1989-11-01), Dix et al.
patent: 5085947 (1992-02-01), Saito et al.
patent: 5085974 (1992-02-01), Frass et al.
patent: 5239405 (1993-08-01), Varaprasad et al.
patent: 5344928 (1994-09-01), Masuya et al.
patent: 5358876 (1994-10-01), Inoue et al.
patent: 5532171 (1996-07-01), Motsenbocker
patent: 5545516 (1996-08-01), Wagner
patent: 5611793 (1997-03-01), Wilson et al.
patent: 5685994 (1997-11-01), Johnson
patent: 5882627 (1999-03-01), Pomerantz
patent: 6183764 (2001-02-01), Shanbrom
patent: 6251127 (2001-06-01), Biel
patent: 6551346 (2003-04-01), Crossley
patent: 6562295 (2003-05-01), Neuberger
patent: 6623513 (2003-09-01), Biel
patent: 6952392 (2005-10-01), Vig et al.
patent: 7101977 (2006-09-01), Rosenblum et al.
patent: 7176308 (2007-02-01), Vig et al.
patent: 7220879 (2007-05-01), Bass et al.
patent: 7229447 (2007-06-01), Biel
patent: 7371744 (2008-05-01), Brown et al.
patent: 2002/0061330 (2002-05-01), Chowdhary et al.
patent: 2002/0183808 (2002-12-01), Biel
patent: 2003/0158204 (2003-08-01), Galey
patent: 2004/0055965 (2004-03-01), Hubig et al.
patent: 2004/0147508 (2004-07-01), Brown et al.
patent: 2004/0213736 (2004-10-01), Wischik et al.
patent: 2007/0161625 (2007-07-01), Brown et al.
patent: 19640758 (1999-11-01), None
patent: 0128414 (1984-12-01), None
patent: 2373787 (2002-02-01), None
patent: 63187154 (1988-08-01), None
patent: 2001124699 (2001-05-01), None
patent: WO 91/16911 (1991-11-01), None
patent: WO 96/30766 (1996-10-01), None
patent: WO 99/25314 (1999-05-01), None
patent: WO 01/62289 (2001-08-01), None
patent: WO 01/70699 (2001-09-01), None
patent: WO 02/096896 (2002-12-01), None
STN Registry No. 61-73-4. “Methylene Blue”. STN Registry Database. p. 1-2. Retrieved May 21, 2009.
U.S. Appl. No. 12/078,805, filed Apr. 4, 2008.
U.S. Appl. No. 12/149,996, filed May 12, 2008.
U.S. Appl. No. 12/171,121, filed Jul. 10, 2008.
U.S. Appl. No. 12/141,747, filed Jun. 18, 2008.
www.sigma-aldrich.com, M9140 Methylene Blue, (2006).
www.sigma-aldrich.com, T3260 Toluidine Blue O, (2006).
www.sigma-aldrich.com, T7029 Thionin acetate, (2006).
www.sigma-aldrich.com, A6270 Azure A chloride, (2006).
www.sigma-aldrich.com, A4043 Azure B, (2006).
www.sigma-aldrich.com, 11667 Azure C, (2006).
www.sigma-aldrich.com, 302643 Trypan Blue, (2006).
www.sigma-aldrich.com, 211109 Methylene Green zinc chloride double salt, (2006).
www.sigma-aldrich.com, N3013 Nile Red, (2006).
“Methylene Blue” (Monograph No. 5979). The Merck Index (Eleventh Edition). Merck & Co., Inc., p. 954 (1989).
Poster titled “In Vitro Photodynamic Activity of a Series of novel Methylene Blue Analogues” by Mellish et al, Centre for Photobiology and Photodynamic Therapy, 1 page, Jul. 2000.
Wainwright et al, “Photobactericidal Activity of Phenothiazinium Dyes Against Methicillin-Resistant Strans ofStaphylococcus aureus”, FEMS Microbiology Letters, 160:177-181 (1998).
Valduga et al, “Effect of extracellularly generated singlet oxygen on Gram-positive and Gram-negative bacteria”, J. Photochem. Photobiol. B: Biol. 21:81-86 (1993).
Weng et al, “Adsorption of a cationic dye (methylene blue) onto spent activated clay”, Journal of Hazardous Materials 144:355-362 (2007).
Gürses et al, “The adsorption kinetics of the cationic dye, methylene blue, onto clay”, Journal of Hazardous Materials B131:217-228 (2006).
Methylene blue clay test kit, Website accessed Aug. 9, 2007, http://www.ofite.com/products/Drilling/Kits/168-00.htm.
Fujii et al, “Synthesis of 2-(D-Arabino-tetra-hydroxybutyl)pyrazine-5-sulfonic Acid”, Agric. Biol. Chem. 46(8):2169-2172 (1982).
Wainwright et al, “Increased cytotoxicity and phototoxicity in the methylene blue series via chromophore methylation”, Journal of Photochemistry and Photobiology B: Biology 40:233-239 (1997).
Wainwright, “Photodynamic therapy—from dyestuffs to high-tech clinical practice”, Rev. Prog. Color. 34:95-109 (2004).
Wainwright, “Photodynamic antimicrobial chemotherapy (PACT)”, Journal of Antimicrobial Chemotherapy 42:13-28 (1998).
Kiernan, Dyes and other colorants in microtechnique and biomedical research Color. Technol. 122:1-21 (2006).
Wainwright, “Non-porphyrin Photosensitizers in Biomedicine”, Chemical Society Reviews, pp. 351-359 (1996).
Colour Index, Third Edition, vol. 4 (1971), (The Society of Dyers and Colourists/American Association of Textile Chemists and Colorists), http://www.colour-index.org.
The Sigma-Aldrich Handbook of Stains, Dyes and Indicators, Floyd J. Green (Aldrich Chemical Company Inc., Milwaukee, Wisconsin (1990).
Stains and Dyes—Certified and Non-Certified, http://www.sigmaaldrich.com [http://www.sigmaaldrich.com/Area—of—Interest/Research—Essentials/Hematology—and—Histology/Product—Lines/Stains—and—Dyes.html.].
Bernthsen, “Studien in der Methylenblaugruppe”, Justus Liebig's Annalen Der Chemie 251, Abschnitt 6, Homologe Indamine und Thioninfarbstoffe, pp. 83-97 (1888) and English Translation.
Moura et al, “Synthetic routes to 3,7-bis(dialkylamino)phenothiazin-5-ium compounds”, Current Drug Targets 4(2):133-142 (2003).
http://photopharmica.com
ews/01—07—07.htm, (2007) “Photopharmica . . . Phase II Data”.
Mellish et al, “In Vitro Photodynamic Activity of a Series of Methylene Blue Analogues”, Photochemistry and Photobiology 75(4):392-397 (2002).
Merriam-Webster Dictinary [Online], “Remove”. [Retrived Mar. 16, 2007]. Retrieved from the Internet: <URL:http://www.m-w.com/dictinoary/remove.>.
Mutschler et al, “Drug Actions” Basic Principles and Therapeutic Aspects, Medpharm Scientific Publishers, pp. 515-580 (1995).
Stains File, internet resource for histotechnologists, http://stainsfile.info/StainsFile/theory/solvent.htm, May 2005.
Office Action dated Jun. 16, 2009 from U.S. Appl. No. 12/078,805.
Office Action dated Jun. 12, 2009 from U.S. Appl. No. 12/141,747.
Merriam-Webster Dictionary [Online], “Deactivate”. [Retrieved Jun. 10, 2009]. Retrieved from the Internet: <URL:http//www.m-w.com/dictionary/deactivate>, 2009.
Corriere et al, “MRSA: An Evolving Pathogen”, Disease-A-Month. Dec. 2008; 54(12):751-755.
Office Action dated Jan. 12, 2010 from U.S. Appl. No. 12/149,996.
Brown Stanley Beames
Griffiths John
Mellish Kirste Joanne
O'Grady Cassandra Claire
Roberts David John Howard
Nixon & Vanderhye P.C.
Photopharmica Limited
Royds Leslie A
LandOfFree
Biologically active methylene blue derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Biologically active methylene blue derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biologically active methylene blue derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4181921